FDG positron emission tomography for the detection of ovarian cancer.
FDG positron emission tomography for the detection of ovarian cancer. [electronic resource]
- TEC bulletin Jul 2002
- 10-3 p. digital
Publication Type: Journal Article
1543-1622
Blue Cross Blue Shield Insurance Plans
Drug Approval
Female
Flow Cytometry
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Follow-Up Studies
Humans
Insurance Coverage
Neoplasm Recurrence, Local--diagnostic imaging
Outcome Assessment, Health Care
Ovarian Neoplasms--diagnostic imaging
Radiopharmaceuticals
Technology Assessment, Biomedical
Tomography, Emission-Computed
United States
Publication Type: Journal Article
1543-1622
Blue Cross Blue Shield Insurance Plans
Drug Approval
Female
Flow Cytometry
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Follow-Up Studies
Humans
Insurance Coverage
Neoplasm Recurrence, Local--diagnostic imaging
Outcome Assessment, Health Care
Ovarian Neoplasms--diagnostic imaging
Radiopharmaceuticals
Technology Assessment, Biomedical
Tomography, Emission-Computed
United States